Related Experiment Video
Updated: Jul 17, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Mortality related to cerebrovascular disease in systemic lupus erythematosus
S Bernatsky1, A Clarke, D D Gladman
1Division of Clinical Epidemiology, Montreal General Hospital, Montreal, Quebec, Canada.
Insights
Systemic lupus erythematosus (SLE) patients face double the risk of death from cerebrovascular disease compared to the general population. This increased risk, particularly for ill-defined events, highlights a critical area for further research in SLE patient care.
Area of Science:
- Neurology
- Rheumatology
- Epidemiology
Background:
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with known associations to cardiovascular complications.
- Cerebrovascular disease (CVD) is a significant cause of morbidity and mortality, but its specific impact in SLE patients requires further elucidation.
Purpose of the Study:
- To investigate and quantify the mortality rates associated with cerebrovascular disease in a Canadian cohort of SLE patients.
- To compare these mortality rates against those observed in the general population.
Main Methods:
- Utilized a multisite Canadian SLE cohort comprising 2688 patients.
- Ascertained deaths due to cerebrovascular disease through vital statistics registry linkage using International Classification of Diseases (ICD) codes.
- Calculated standardized mortality ratios (SMR) to compare observed versus expected deaths.
Main Results:
- The overall standardized mortality ratio (SMR) for cerebrovascular disease death in SLE patients was 2.0 (95% CI 1.0, 3.7), indicating a doubled risk.
- Significantly elevated SMRs were observed for ill-defined cerebrovascular events (SMR 44.9) and other cerebrovascular diseases (SMR 8.4).
- Cerebral hemorrhages and other cerebrovascular events appeared more common causes of death than cerebral infarctions.
Conclusions:
- Mortality related to cerebrovascular disease is increased in SLE patients compared to the general population.
- The high SMR for ill-defined cerebrovascular events may suggest undiagnosed cerebral vasculitis or diagnostic challenges in SLE.
- Factors such as thrombocytopenia or anticoagulation may contribute to the higher incidence of cerebral hemorrhage in SLE patients.
Abstract:
The objective of this study was to examine mortality rates related to cerebrovascular disease in systemic lupus erythematosus (SLE) compared to the general population. Our sample was a multisite Canadian SLE cohort (10 centres, n = 2688 patients). Deaths due to cerebrovascular disease were ascertained by vital statistics registry linkage using ICD diagnostic codes. Standardized mortality ratio (SMR, ratio of deaths observed to expected) estimates were calculated. The total SMR for death due to cerebrovascular disease was 2.0 (95% confidence interval [CI] 1.0, 3.7). When considering specific types of events, the category with the greatest increased risk was that of ill-defined cerebrovascular events (SMR 44.9 95% CI 9.3, 131.3) and other cerebrovascular disease (SMR 8.4, 95% CI 2.3, 21.6). Deaths due to cerebral infarctions appeared to be less common than hemorrhages and other types of cerebrovascular events. Our data suggest an increase in mortality related to cerebrovascular disease in SLE patients compared to the general population. The large increase in ill-defined cerebrovascular events may represent cases of cerebral vasculitis or other rare forms of nervous system disease; alternately, it may reflect diagnostic uncertainty regarding the etiology of some clinical presentations in SLE patients. The suggestion that more deaths are attributed to cerebral hemorrhage, as opposed to infarction, indicates that inherent or iatrogenic factors (eg, thrombocytopenia or anticoagulation) may be important. In view of the paucity of large-scale studies of mortality attributed to neuropsychiatric outcomes in SLE, our findings highlight the need for additional research in large SLE cohorts.
Related Concept Videos
Hemorrhagic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Cerebral Edema ll: Pathophysiology
Ischemic Stroke ll: Pathophysiology
Dementia l: Introduction
Ischemic Stroke l: Introduction
